The head of the Iranian Children’s Blood and Plasma Association says the initial results of the plasma therapy of corona patients in Iran have been positive and promising.
Hassan Abolqasemi said the first step of research on plasma treatment of corona patients has been completed.
In the first stage, he noted, the plasma of the recovered patients was injected to 50 people who were either seriously ill or in critical condition. Although the final results of the study have not yet been announced, evaluations show the timing of plasma injection in COVID-19 patients is of great importance in improving their condition.
The group of patients, who received plasma during the first week of hospitalisation, recovered more rapidly and a significant number of them were discharged; but the recovery rate was lower among patients hospitalised for more than a week. So, one hypothesis is that if the plasma is injected in the early days of the disease, the chances of patients recovery will increase, he continued.
“In the next step, the patients were divided into two groups. The first group received plasma and the second group remained without plasma,” ISNA quoted the head of the Corona Plasma Treatment Research Team as saying.
The results of the study of these two groups show that plasma injection has significant positive results, underlined Abolqassemi, saying although the scientific result of the work has not been published yet, plasma injection has had a definite positive effect on many patients.